These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19763701)

  • 1. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.
    Likui W; Hong W; Shuwen Z
    J Gastrointest Surg; 2010 Jan; 14(1):74-81. PubMed ID: 19763701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of osteopontin as a therapeutic target for human colorectal cancer.
    Likui W; Hong W; Shuwen Z; Yuangang Y; Yan W
    J Gastrointest Surg; 2011 Apr; 15(4):652-9. PubMed ID: 21318445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
    Gao JY; Song BR; Peng JJ; Lu YM
    World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
    Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
    Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of osteopontin expression in melanoma progression.
    Kiss T; Ecsedi S; Vizkeleti L; Koroknai V; Emri G; Kovács N; Adany R; Balazs M
    Tumour Biol; 2015 Sep; 36(10):7841-7. PubMed ID: 25944164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
    Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
    Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
    Huang J; Pan C; Hu H; Zheng S; Ding L
    PLoS One; 2012; 7(10):e47901. PubMed ID: 23112867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
    Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of microRNA-16 expression in human colorectal cancer.
    Qian J; Jiang B; Li M; Chen J; Fang M
    World J Surg; 2013 Dec; 37(12):2944-9. PubMed ID: 24045965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer.
    Wei R; Wong JPC; Lyu P; Xi X; Tong O; Zhang SD; Yuen HF; Shirasawa S; Kwok HF
    J Cell Mol Med; 2018 Sep; 22(9):4097-4105. PubMed ID: 29851214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrate suppresses mRNA increase of osteopontin and cyclooxygenase-2 in human colon tumor tissue.
    Jahns F; Wilhelm A; Jablonowski N; Mothes H; Radeva M; Wölfert A; Greulich KO; Glei M
    Carcinogenesis; 2011 Jun; 32(6):913-20. PubMed ID: 21459756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis.
    Zhao M; Liang F; Zhang B; Yan W; Zhang J
    Sci Rep; 2015 Aug; 5():12713. PubMed ID: 26234583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.
    Hao C; Cui Y; Lane J; Jia S; Ji J; Jiang WG
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
    Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
    Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.